Reassortant strain of influenza virus a / 17 / thailand / 2022 / 168 (H3N2) for production of live influenza intranasal vaccine for adults and children

RU2864983C1Active Publication Date: 2026-06-30FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE NAUCHNOE UCHREZHDENIE INSTITUT EKSPERIMENTALNOJ MEDITSINY (FGBNU IEM)
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
RU2025134779
Authority / Receiving Office
RU · RU
Patent Type
Patents
Current Assignee / Owner
Filing Date
2025-12-09
Publication Date
2026-06-30
Estimated Expiration
2045-12-09

Smart Images

  • Figure 00000001
    Figure 00000001
  • Figure 00000002
    Figure 00000002
  • Figure 00000003
    Figure 00000003
Patent Text Reader

Abstract

FIELD: medical virology.SUBSTANCE: reassortant strain of influenza virus A / 17 / Thailand / 2022 / 168 (H3N2) has been proposed. The influenza virus strain A / 17 / Thailand / 2022 / 168 (H3N2) has been deposited in the State Collection of Viruses named after D.I. Ivanovsky of FSBI National Research Center for Epidemiology and Microbiology named after the honorary academician N. F. Gamaleya of the Ministry of Health of the Russian Federation under No. 3081.EFFECT: obtaining a live intranasal influenza vaccine for the prevention of influenza among adults and children.1 cl, 5 tbl
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Separated H3N2 influenza virus strain and application thereof

    CN112522213A

  • Strain of influenza virus a / 17 / victoria / 2011 / 89 (H3N2) for production of live influenza intranasal vaccine for adults and children

    RU2532844C2

  • Reassortant strain of influenza virus a / 17 / sydney / 2019 / 156 (H3N2) for the production of live intranasal influenza vaccine for adults and children

    RU2783876C1

  • Reassortant vaccine strain of influenza a / 17 / darwin / 2021 / 410 (H3N2) virus for production of live influenza intranasal vaccine for adults and children

    RU2825673C1